Skip to main content
Erschienen in: Virchows Archiv 6/2012

01.12.2012 | Original Article

Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading

verfasst von: Valeria Barresi, Luca Reggiani Bonetti, Giovanni Branca, Carmela Di Gregorio, Maurizio Ponz de Leon, Giovanni Tuccari

Erschienen in: Virchows Archiv | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

The most widely used system to define the histological grade of colorectal carcinoma (CRC) is based on the degree of gland formation. This system suffers from significant interobserver variability which may limit its prognostic value and consequently better standardized criteria for the assessment of histological grading of CRC are needed. The present study aims to evaluate and to compare, in a cohort of postsurgical pTNM stage I CRC, conventional histological grading, and a novel grading system based on the number of poorly differentiated clusters of neoplastic cells, in terms of interobserver reproducibility, prognostic significance on progression-free survival, and association with other clinicopathological characteristics. Grading with both systems was performed by two pathologists independently and blinded to the clinicopathological data. Interobserver agreement was higher when grade was assessed by counting poorly differentiated clusters than by assessing the relative proportion of the glandular component. Contrary to conventional grading, the novel system provided significant prognostic information in terms of progression-free survival and was significantly associated with budding, invasive growth, lymphatic invasion, and occult nodal metastases of CRC. In conclusion, our findings suggest that a tumor grading system based on the number of poorly differentiated clusters is more reproducible and provides better prognostic stratification of pTNM stage I CRC patients than conventional grading.
Literatur
1.
Zurück zum Zitat Landis SH, Murray T, Bolden S (1999) Cancer statistics. Cancer J Clin 49:8–31CrossRef Landis SH, Murray T, Bolden S (1999) Cancer statistics. Cancer J Clin 49:8–31CrossRef
2.
Zurück zum Zitat Wiggers T, Arends JW, Schutter B et al (1988) A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 61:386–395PubMedCrossRef Wiggers T, Arends JW, Schutter B et al (1988) A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 61:386–395PubMedCrossRef
3.
Zurück zum Zitat Wu XC, Chen VW, Steele B et al (2001) Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group. Cancer 92:2547–2554CrossRef Wu XC, Chen VW, Steele B et al (2001) Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group. Cancer 92:2547–2554CrossRef
4.
Zurück zum Zitat Di Gregorio C, Fante R, Roncucci L et al (1996) Clinical features, frequency and prognosis of Dukes’ A colorectal carcinoma: a population-based investigation. Eur J Cancer 32A:1957–1962PubMedCrossRef Di Gregorio C, Fante R, Roncucci L et al (1996) Clinical features, frequency and prognosis of Dukes’ A colorectal carcinoma: a population-based investigation. Eur J Cancer 32A:1957–1962PubMedCrossRef
5.
Zurück zum Zitat Barresi V, Reggiani-Bonetti L, Di Gregorio C et al (2010) Stage I colorectal carcinoma: vascular endothelial growth factor (VEGF) immunohistochemical expression, microvessel density and their correlation with clinical outcome. Virchows Arch 457:11–19PubMedCrossRef Barresi V, Reggiani-Bonetti L, Di Gregorio C et al (2010) Stage I colorectal carcinoma: vascular endothelial growth factor (VEGF) immunohistochemical expression, microvessel density and their correlation with clinical outcome. Virchows Arch 457:11–19PubMedCrossRef
6.
Zurück zum Zitat Barresi V, Ieni A, Reggiani-Bonetti L, Di Gregorio C et al (2011) Neutrophil gelatinase-associated lipocalin (NGAL): a new prognostic marker in stage I colorectal carcinoma? Hum Pathol 42:1720–1726PubMedCrossRef Barresi V, Ieni A, Reggiani-Bonetti L, Di Gregorio C et al (2011) Neutrophil gelatinase-associated lipocalin (NGAL): a new prognostic marker in stage I colorectal carcinoma? Hum Pathol 42:1720–1726PubMedCrossRef
7.
Zurück zum Zitat Barresi V, Reggiani-Bonetti L, Di Gregorio C et al (2011) Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. J Clin Pathol 64:6–12PubMedCrossRef Barresi V, Reggiani-Bonetti L, Di Gregorio C et al (2011) Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma. J Clin Pathol 64:6–12PubMedCrossRef
8.
Zurück zum Zitat Barresi V, Reggiani-Bonetti L, Di Gregorio C et al (2011) Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. Pathol Res Pract 207:479–486PubMedCrossRef Barresi V, Reggiani-Bonetti L, Di Gregorio C et al (2011) Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma. Pathol Res Pract 207:479–486PubMedCrossRef
9.
Zurück zum Zitat Barresi V, Reggiani-Bonetti L, Vitarelli E et al (2012) Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol 36:66–72PubMedCrossRef Barresi V, Reggiani-Bonetti L, Vitarelli E et al (2012) Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol 36:66–72PubMedCrossRef
10.
Zurück zum Zitat Freedman LS, Macaskill P, Smith AN (1984) Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 29:733–736CrossRef Freedman LS, Macaskill P, Smith AN (1984) Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 29:733–736CrossRef
11.
Zurück zum Zitat Fisher ER, Sass R, Palekar A et al (1989) Dukes’ classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). Cancer 64:2354–2360PubMedCrossRef Fisher ER, Sass R, Palekar A et al (1989) Dukes’ classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01). Cancer 64:2354–2360PubMedCrossRef
12.
Zurück zum Zitat Blenkinsopp WK, Stewart-Brown S, Blesovsky L et al (1981) Histopathology reporting in large bowel cancer. J Clin Pathol 34:509–513PubMedCrossRef Blenkinsopp WK, Stewart-Brown S, Blesovsky L et al (1981) Histopathology reporting in large bowel cancer. J Clin Pathol 34:509–513PubMedCrossRef
13.
Zurück zum Zitat Thomas GDH, Dixon MF, Smeeton NC et al (1983) Observer variation in the histological grading of rectal carcinoma. J Clin Pathol 36:385–391PubMedCrossRef Thomas GDH, Dixon MF, Smeeton NC et al (1983) Observer variation in the histological grading of rectal carcinoma. J Clin Pathol 36:385–391PubMedCrossRef
14.
Zurück zum Zitat Chandler I, Houlston RS (2008) Interobserver agreement in grading of colorectal cancers-findings from a nationwide web-based survey of histopathologists. Histopathology 52:494–499PubMedCrossRef Chandler I, Houlston RS (2008) Interobserver agreement in grading of colorectal cancers-findings from a nationwide web-based survey of histopathologists. Histopathology 52:494–499PubMedCrossRef
15.
Zurück zum Zitat Ueno H, Kajiwara Y, Shimazaki H et al (2012) New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 36:193–201PubMedCrossRef Ueno H, Kajiwara Y, Shimazaki H et al (2012) New criteria for histologic grading of colorectal cancer. Am J Surg Pathol 36:193–201PubMedCrossRef
16.
Zurück zum Zitat Hamilton SR, Volgelstein B, Kudo S et al (2000) Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 110–111 Hamilton SR, Volgelstein B, Kudo S et al (2000) Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA (eds) Pathology and genetics of tumours of the digestive system. IARC Press, Lyon, pp 110–111
17.
Zurück zum Zitat Hamilton SR, Bosman FT, Boffetta P (2010) Carcinoma of the colon and rectum. In: Bosman T, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system. IARC Press, Lyon, pp 138–139 Hamilton SR, Bosman FT, Boffetta P (2010) Carcinoma of the colon and rectum. In: Bosman T, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of tumours of the digestive system. IARC Press, Lyon, pp 138–139
18.
Zurück zum Zitat Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours. Wiley, New York Sobin L, Gospodarowicz M, Wittekind C (2009) TNM classification of malignant tumours. Wiley, New York
19.
Zurück zum Zitat Kikuchi R, Takano M, Takagi K et al (1995) Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 38:1286–1895PubMedCrossRef Kikuchi R, Takano M, Takagi K et al (1995) Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 38:1286–1895PubMedCrossRef
20.
Zurück zum Zitat Morodomi T, Isomoto H, Shirouzu G et al (1989) An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancers. Cancer 63:539–643PubMedCrossRef Morodomi T, Isomoto H, Shirouzu G et al (1989) An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancers. Cancer 63:539–643PubMedCrossRef
21.
Zurück zum Zitat Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg 239:34–42PubMedCrossRef Ueno H, Mochizuki H, Hashiguchi Y et al (2004) Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg 239:34–42PubMedCrossRef
22.
Zurück zum Zitat Reggiani Bonetti L, Di Gregorio C et al (2011) Lymph node micrometastasis and survival of patients with stage I (Dukes’ A) colorectal carcinoma. Scand J Gastroenterol 46:881–886PubMedCrossRef Reggiani Bonetti L, Di Gregorio C et al (2011) Lymph node micrometastasis and survival of patients with stage I (Dukes’ A) colorectal carcinoma. Scand J Gastroenterol 46:881–886PubMedCrossRef
23.
Zurück zum Zitat Lips DJ, Koebrugge B, Liefers GJ et al (2011) The influence of micrometastases on prognosis and survival in stage I–II colon cancer patients: the Enroute study. BMC Surg 11:11PubMedCrossRef Lips DJ, Koebrugge B, Liefers GJ et al (2011) The influence of micrometastases on prognosis and survival in stage I–II colon cancer patients: the Enroute study. BMC Surg 11:11PubMedCrossRef
24.
Zurück zum Zitat Stewart FW, Spies JW (1929) Biopsy histology in the grading of rectal carcinoma. Am J Pathol 5:109–115PubMed Stewart FW, Spies JW (1929) Biopsy histology in the grading of rectal carcinoma. Am J Pathol 5:109–115PubMed
25.
Zurück zum Zitat Dukes C (1937) Histological grading of rectal cancer. Proc R Soc Med 30:371–376PubMed Dukes C (1937) Histological grading of rectal cancer. Proc R Soc Med 30:371–376PubMed
26.
Zurück zum Zitat Grinnell RS (1939) The grading and prognosis of carcinoma of the colon and rectum. Ann Surg 109:500–533PubMedCrossRef Grinnell RS (1939) The grading and prognosis of carcinoma of the colon and rectum. Ann Surg 109:500–533PubMedCrossRef
27.
Zurück zum Zitat Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124:979–994PubMed Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 124:979–994PubMed
28.
Zurück zum Zitat Nicastri DG, Doucette JT, Godfrey TE et al (2007) Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 9:563–571PubMedCrossRef Nicastri DG, Doucette JT, Godfrey TE et al (2007) Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature. J Mol Diagn 9:563–571PubMedCrossRef
29.
Zurück zum Zitat Greenson JK, Isenhart CE, Rice R et al (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73:563–569PubMedCrossRef Greenson JK, Isenhart CE, Rice R et al (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 73:563–569PubMedCrossRef
30.
Zurück zum Zitat Hayashi N, Ito I, Yanagisawa A, Kato Y et al (1995) Genetic diagnosis of lymph node metastasis in colorectal cancer. Lancet 345:1257–1259PubMedCrossRef Hayashi N, Ito I, Yanagisawa A, Kato Y et al (1995) Genetic diagnosis of lymph node metastasis in colorectal cancer. Lancet 345:1257–1259PubMedCrossRef
31.
Zurück zum Zitat Mescoli C, Albertoni L, Pucciarelli S et al (2012) Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol 30:965–971PubMedCrossRef Mescoli C, Albertoni L, Pucciarelli S et al (2012) Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol 30:965–971PubMedCrossRef
Metadaten
Titel
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading
verfasst von
Valeria Barresi
Luca Reggiani Bonetti
Giovanni Branca
Carmela Di Gregorio
Maurizio Ponz de Leon
Giovanni Tuccari
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 6/2012
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-012-1326-8

Weitere Artikel der Ausgabe 6/2012

Virchows Archiv 6/2012 Zur Ausgabe

Neu im Fachgebiet Pathologie